4//SEC Filing
Stone Christopher Lewis 4
Accession 0001437749-13-000784
CIK 0000882104other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:03 PM ET
Size
5.0 KB
Accession
0001437749-13-000784
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common Stock
2013-01-24$6.72/sh+16,458$110,598→ 76,670 total
Footnotes (1)
- [F1]The shares will vest on December 12, 2014, provided Mr. Stone is continuously employed by the Company through such date. In the event Mr. Stone is terminated by PDLI without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Mr. Stone has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDLI. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 7:03 PM ET
- Size
- 5.0 KB